Results 91 to 100 of about 30,547 (198)

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

open access: yesNature Communications, 2018
Declining NAD+ levels have been linked to aging-associated pathologies. Here the authors present results of a double-blind, randomized crossover trial on 30 healthy middle-aged individuals to show that nicotinamide riboside effectively elevates NAD ...
Christopher R. Martens   +7 more
doaj   +1 more source

Additional file 1: of The NAD+ precursor nicotinamide riboside decreases exercise performance in rats

open access: yes, 2016
Raw data of time to exhaustion in the incremental swimming test for the control and the nicotinamide riboside group.
Vassilis Paschalis (380711)   +10 more
core   +1 more source

COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS

open access: yes, 2023
The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of promoting protective immunity and/or for preventing and/or treating bacterial or viral infections and/or for limiting immune mediated
Giroud-Gerbetant, Judith   +6 more
core  

THE PHOSPHOROLYSIS OF NICOTINAMIDE RIBOSIDE

open access: yesJournal of Biological Chemistry, 1951
J W, ROWEN, A, KORNBERG
openaire   +2 more sources

An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR)

open access: yesFood Frontiers
The study of nicotinamide adenine dinucleotide (NAD+) biology has gained popularity recently. Research discovered that two NAD+ biosynthesis intermediates, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are biosynthetic precursors of ...
Xu Yang   +6 more
doaj   +1 more source

Restorin® NR is a Highly Efficient NAD+ Precursor

open access: yesDrug Design, Development and Therapy
Brett Weiss,1 Rui Cao,1 Yongzheng Liu,2,3 Jiaqi Chen,2,4 George L Marshall11Seragon Biosciences, Irvine, CA, USA; 2Sinopharm-Seragon Biosciences, Beijing, People’s Republic of China; 3School of Medicine, Tsinghua University, Beijing, People’s Republic of
Weiss B   +4 more
doaj  

Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction‐Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase‐Mediated Nicotinamide Dinucleotide Levels

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiorenal syndrome type 1 is characterized by the development of acute kidney injury following acute cardiac illness and notably acute myocardial infarction (MI).
Nada J. Habeichi   +9 more
doaj   +1 more source

Differentially disrupted spinal cord and muscle energy metabolism in spinal and bulbar muscular atrophy

open access: yesJCI Insight
Prior studies showed that polyglutamine-expanded androgen receptor (AR) is aberrantly acetylated and that deacetylation of the mutant AR by overexpression of nicotinamide adenine dinucleotide–dependent (NAD+-dependent) sirtuin 1 is protective in cell ...
Danielle DeBartolo   +5 more
doaj   +1 more source

Corrigendum to 'Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice'. [PDF]

open access: yesNeurotherapeutics
Lo'pez-Blanch R   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy